
Company Update
David Immelman DXS International plc | 01252 719800 |
AQSE Corporate Broker and Corporate Advisor Hybridan LLP Claire Louise Noyce | 020 3764 2341 |
Notes to Editors
About DXS:
DXS International presents up to date treatment guidelines and recommendations, from Clinical Commissioning Groups and other trusted NHS sources, to doctors, nurses and pharmacists in their workflow and during the patient consultation. This effective clinical decision support ultimately translates to improved healthcare outcomes delivered more cost effectively and which should significantly contribute towards the NHS achieving its projected efficiency savings.


Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Passport Global Secures U.S. Customs License, Expands Brokerage Across All U.S. Ports
- Markets4you Celebrates 18 Years With Global Recognition, New Features, And Expanded Trading Options
- Variational Announces $1.5 Million Strategic Round And Launches Referral Program
- $ZEUS Marking His Territory: Announcing An IP Collaboration With Original Zeus Artist And Trademark Holder
- Zircuit Joins Binance Alpha: ZRC Airdrop & Trading Competition Go Live
- Meta Earth Network 2.0: Pioneering Web3 Innovation With Rewards And Global Events
Comments
No comment